Literature DB >> 27990492

The Orphan C2orf40 Gene is a Neuroimmune Factor in Alzheimer's Disease.

Sonia Podvin1, Miles C Miller2, Ryan Rossi3, Jasmine Chukwueke3, John E Donahue3, Conrad E Johanson4, Andrew Baird5, Edward G Stopa2.   

Abstract

Expression of the orphan C2orf40 gene is associated with the aggregation of the neurofibrillary tangle-protein tau in transgenic mice, tumor suppression, the induction of senescence in CNS, and the activation of microglia and peripheral mononuclear leukocytes. This gene also encodes several secreted pro- and anti-inflammatory neuropeptide-like cytokines, suggesting they might be implicated in the inflammatory component(s) of Alzheimer's disease (AD). Accordingly, we evaluated human AD and control brains for expression changes by RT-qPCR, Western blot, and histological changes by immunolabeling. RT-qPCR demonstrated increased cortical gene expression in AD. The molecular form of Ecrg4 detected in cortex was 8-10 kDa, which was shown previously to interact with the innate immunity receptor complex. Immunocytochemical studies showed intensely stained microglia and intravascular blood-borne monocytes within cerebral cortical white matter of AD patients. Staining was diminished within cortical neurons, except for prominent staining in neurofibrillary tangles. Choroid plexuses showed a decreasing trend. These findings support our hypothesis that c2orf40 participates in the neuroimmune response in AD.

Entities:  

Keywords:  Alzheimer’s disease; Ecrg4; Neurofibrillary tangle; Neuroimmune mechanisms; White matter

Year:  2016        PMID: 27990492      PMCID: PMC5157699     

Source DB:  PubMed          Journal:  JSM Alzheimers Dis Relat Dement        ISSN: 2378-9565


  53 in total

1.  White matter integrity correlates of implicit sequence learning in healthy aging.

Authors:  Ilana J Bennett; David J Madden; Chandan J Vaidya; James H Howard; Darlene V Howard
Journal:  Neurobiol Aging       Date:  2010-05-07       Impact factor: 4.673

2.  Thrombin-processed Ecrg4 recruits myeloid cells and induces antitumorigenic inflammation.

Authors:  Jisook Lee; Xitong Dang; Alexandra Borboa; Raul Coimbra; Andrew Baird; Brian P Eliceiri
Journal:  Neuro Oncol       Date:  2014-11-05       Impact factor: 12.300

3.  [Cloning and identification of cDNA fragments related to human esophageal cancer].

Authors:  T Su; H Liu; S Lu
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1998-07

4.  Esophageal cancer-related gene-4 (ECRG4) interactions with the innate immunity receptor complex.

Authors:  Sonia Podvin; Xitong Dang; Morgan Meads; Arwa Kurabi; Todd Costantini; Brian P Eliceiri; Andrew Baird; Raul Coimbra
Journal:  Inflamm Res       Date:  2014-12-16       Impact factor: 4.575

Review 5.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

6.  Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.

Authors:  Mark Yarchoan; Sharon X Xie; Mitchel A Kling; Jon B Toledo; David A Wolk; Edward B Lee; Vivianna Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Steven E Arnold
Journal:  Brain       Date:  2012-11-30       Impact factor: 13.501

7.  Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo.

Authors:  Lin-Wei Li; Xi-Ying Yu; Yang Yang; Chun-Peng Zhang; Li-Ping Guo; Shih-Hsin Lu
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

8.  Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.

Authors:  Dietmar Rudolf Thal; Christine A F von Arnim; W Sue T Griffin; Robert E Mrak; Lauren Walker; Johannes Attems; Thomas Arzberger
Journal:  J Neural Transm (Vienna)       Date:  2015-01-04       Impact factor: 3.575

9.  Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer.

Authors:  Renaud Sabatier; Pascal Finetti; José Adelaide; Arnaud Guille; Jean-Paul Borg; Max Chaffanet; Lydie Lane; Daniel Birnbaum; François Bertucci
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

10.  Transmigration of polymorphnuclear neutrophils and monocytes through the human blood-cerebrospinal fluid barrier after bacterial infection in vitro.

Authors:  Ulrike Steinmann; Julia Borkowski; Hartwig Wolburg; Birgit Schröppel; Peter Findeisen; Christel Weiss; Hiroshi Ishikawa; Christian Schwerk; Horst Schroten; Tobias Tenenbaum
Journal:  J Neuroinflammation       Date:  2013-02-28       Impact factor: 8.322

View more
  5 in total

Review 1.  Potential functions of esophageal cancer-related gene-4 in the cardiovascular system.

Authors:  Rui Zhou; Yuanshu Liu; Wenjun Huang; Xitong Dang
Journal:  Front Med       Date:  2019-08-29       Impact factor: 4.592

2.  Ecrg4 peptide is the ligand of multiple scavenger receptors.

Authors:  Tetsuo Moriguchi; Shuji Takeda; Shinzo Iwashita; Kei Enomoto; Tatsuya Sawamura; Uichi Koshimizu; Toru Kondo
Journal:  Sci Rep       Date:  2018-03-06       Impact factor: 4.379

3.  Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review.

Authors:  David Vogrinc; Katja Goričar; Vita Dolžan
Journal:  Front Aging Neurosci       Date:  2021-03-18       Impact factor: 5.750

4.  Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer's disease.

Authors:  Jaeyoon Chung; Xiaoling Zhang; Mariet Allen; Xue Wang; Yiyi Ma; Gary Beecham; Thomas J Montine; Steven G Younkin; Dennis W Dickson; Todd E Golde; Nathan D Price; Nilüfer Ertekin-Taner; Kathryn L Lunetta; Jesse Mez; Richard Mayeux; Jonathan L Haines; Margaret A Pericak-Vance; Gerard Schellenberg; Gyungah R Jun; Lindsay A Farrer
Journal:  Alzheimers Res Ther       Date:  2018-02-20       Impact factor: 6.982

5.  Analysis of Shared Genetic Regulatory Networks for Alzheimer's Disease and Epilepsy.

Authors:  Xiao-Dan Wang; Shuai Liu; Hui Lu; Yalin Guan; Hao Wu; Yong Ji
Journal:  Biomed Res Int       Date:  2021-10-14       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.